Skip to main content
Equibles

Woodline Partners LP

Position in NTLA — Intellia Therapeutics, Inc.

CIK 1784547 San Francisco, CA
Back to NTLA Full portfolio

Position in NTLA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$18,194,905
+$15,618,111 QoQ
Shares Held
1,075,349
+435.0% QoQ
Ownership
0.767%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#28
of 330 holders
Holding Since
Jun 2022
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NTLA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Woodline Partners LP holds $4,400,572,274 across 197 Biotechnology names. NTLA ranks #66 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 2,002,863 $375,096,182
2 PTGX
Protagonist Therapeutics, Inc
 1,414,173 $173,349,326
3 TNGX
Tango Therapeutics, Inc.
 4,000,567 $125,057,724
4 BHVN
Biohaven Ltd.
 7,660,280 $113,984,966
5 COGT
Cogent Biosciences, Inc.
 2,603,162 $100,742,369
6 CYTK
Cytokinetics Inc
 1,100,708 $93,769,314
7 RCUS
Arcus Biosciences, Inc.
 3,007,798 $92,730,412
8 ROIV
Roivant Sciences Ltd.
 2,500,673 $88,498,817

All Filings in NTLA

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $18,194,905 1,075,349
2026-03-31 $2,576,794 200,998
2025-12-31 $1,806,972 200,998
2025-09-30 $3,471,235 200,998
2025-06-30 $11,434,857 1,219,068
2025-03-31 $171,393 24,106
2024-09-30 $9,900,003 481,752
2022-12-31 $17,384,361 498,262
2022-09-30 $19,433,285 347,271
2022-06-30 $3,036,293 58,661